CN Patent

CN115835859A — 包括西他列汀和达格列净的复合制剂以及其制备方法

Assigned to Hanmi Pharmaceutical Co Ltd · Expires 2023-03-21 · 3y expired

What this patent protects

本发明提供一种包括西他列汀和达格列净的复合制剂以及其制备方法。

USPTO Abstract

本发明提供一种包括西他列汀和达格列净的复合制剂以及其制备方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN115835859A
Jurisdiction: CN
Classification: —
Expires: 2023-03-21
Drug substance claim: No
Drug product claim: No
Assignee: Hanmi Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.